CXCL8 and metabolic dysfunction-associated steatohepatitis: SIBO in NASH individuals is also associated with enhanced hepatic expression of TLR4 and release of interleukin (IL)-8 supporting the hypothesis that SIBO may have an important role in NASH development and progression [14].